![](/img/cover-not-exists.png)
Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence
Sai-Hong Ignatius OuVolume:
83
Year:
2012
Language:
english
DOI:
10.1016/j.critrevonc.2011.11.010
File:
PDF, 556 KB
english, 2012